House committee probes NIH (National Institutes of Health) tissue handling
This article was originally published in Clinica
Leaders of the US House energy and commerce committee have launched an investigation into the handling of human tissue samples at the National Institutes of Health (NIH) after learning that the government research institution has almost no accountability for damaged or lost specimens.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.
An AAM-sponsored study by researcher Avalere Health has concluded that Medicare Part D policy changes have led to generics being placed on non-generic tiers 53% of the time in 2020, with generics placed on the ‘preferred generic’ Tier 1 just 10% of the time.